project id: TCGA-LUAD; case submitter id: TCGA-55-A492; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 70; days to birth: -25719; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 25719; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 596.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.917808219178082; pack years smoked: 35.0; years smoked: 33.0; is ffpe: false; composition: Not Reported; days to collection: 31; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-55-A492-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;